PRNewsWire - Health

Actinium Highlights Mutation Agnostic Antileukemic Activity of Actimab-A Against FLT3, NPM1, KMT2A and TP53 Mutations in AML Models Demonstrating Backbone Potential for Acute Myeloid Leukemia Treatment at the American Association for Cancer Research Annual Meeting
Biotin Xtreme Hair Care Redefines Natural Hair Growth Solutions with Salon-Crafted, Plant-Based Formulas
Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation
Chang Robotics Announces Major U.S. Manufacturing Push, $50M Fund Launch, and Breakthrough Innovations for 2025